Delivery Order SPE2DX22D0049-SPE2D826FA3YA
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $128,180.25 on January 15, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract utilizes firm fixed-price pricing with an ultimate completion date of January 16, 2026, and was competitively awarded without any set-aside designation. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $39,805.53 on January 21, 2026, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 22, 2026. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $135,934.08 by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, represents a competitive award with no set-aside designation. The award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $435,766.30 by the Defense Logistics Agency's Medical Supply Chain on January 15, 2026. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of January 16, 2026. The award leverages Amerisourcebergen's extensive capabilities as a critical federal medical supplier, serving military...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $167,368.32 on January 5, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation and an ultimate completion date of January 6, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $110,752.60 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 15, 2026, was competitively awarded with no set-aside designation. The award is issued as a child contract under the parent organization Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,536.55 on January 22, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation. The award is structured as a child contract under Cencora, Inc. (Amerisourcebergen's parent company), leveraging...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $275,058.03 on April 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 24, 2025, and carries no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA3YADelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $415,041.13 on January 26, 2026, by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price contract represents a child order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. No set-aside designation was applied to this award. The contract utilizes the company's comprehensive global pharmaceutical support vehicle to deliver medical supplies and pharmaceuticals in support of military healthcare programs, with performance scheduled to conclude on January 27, 2026. This delivery order exemplifies Amerisourcebergen's critical role as a federal pharmaceutical vendor, supplying essential medical commodities to support Defense Health Agency operations and other government healthcare systems. The award reflects the company's demonstrated capability to meet federal procurement requirements through open competition and its established position as a primary pharmaceutical distributor for military treatment facilities and veteran healthcare programs. Amerisourcebergen operates under parent company Cencora, Inc., which also holds significant federal contracts including a separate IDC with DLA valued at up to $999,999,999.00 through December 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $415.0k | 1/25/26 |